It is a pharma private limited company based in Nagpur, Maharashtra, India, established in 2017.
2017 | Nagpur, Maharashtra, India | ActiveTaraasian Drugs Private Limited, a active private limited company, was established on 19 July 2017 in Nagpur, Maharashtra, India. Engaging in pharma contract r&d within the professional, scientific and technical sector, it holds CIN: U74999MH2017PTC297577. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Its leadership includes Ayesha Shoeb Hashmi (Additional Director), Nitin Uttam Meshram (Director), Shoeb Hashmi (Additional Director). Past directors included Bhushan Bhaskar Marliwar, Nitin Uttam Meshram, Shoeb Hashmi. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No. 10, Ground Floor, Dnyan Yog Appt., Deo Nagar, Khamla Road, Nagpur, Maharashtra, 440015.
U74999MH2017PTC297577
297577
19 July 2017
₹1.00 M
₹1.00 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Taraasian Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ayesha Shoeb Hashmi | Additional Director | 15 Apr 2025 | Current |
| Nitin Uttam Meshram | Director | 13 Jan 2020 | Current |
| Shoeb Hashmi | Additional Director | 15 Apr 2025 | Current |
| Bhupendra Bhaskar Marliwar | Director | 29 Sep 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 03 Apr 2025 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Additional Director | 08 Apr 2018 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Director | 03 Apr 2025 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Taraasian Drugs Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 10.85% decrease. The company also saw a substantial fall in profitability, with a 787.96% decrease in profit. The company's net worth observed a substantial decline by a decrease of 22.32%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Taraasian Drugs had a promoter holding of 87.85% and a public holding of 12.15%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Taraasian Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Taraasian Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Taraasian Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Ayesha Shoeb Hashmi was appointed as a Additional Director was appointed as a Additional Director on 15 Apr 2025 & has been associated with this company since 7 months 18 days . was recorded as a recent event.
The activity Shoeb Hashmi was appointed as a Additional Director was appointed as a Additional Director on 15 Apr 2025 & has been associated with this company since 7 months 18 days . was completed.
Progress on Taraasian Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Taraasian Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
Nitin Uttam Meshram was appointed as a Director was appointed as a Director on 13 Jan 2020 & has been associated with this company since 5 years 10 months . was recorded as a recent event.
The activity Bhupendra Bhaskar Marliwar was appointed as a Director was appointed as a Director on 29 Sep 2017 & has been associated with this company since 8 years 2 months . was completed.
The CIN of Taraasian Drugs Private Limited is U74999MH2017PTC297577.
Taraasian Drugs Private Limited is headquartered at Plot No. 10, Ground Floor, Dnyan Yog Appt., Deo Nagar, Khamla Road, Nagpur, Maharashtra, 440015.
Taraasian Drugs Private Limited was incorporated on 19 July 2017.
The current directors of Taraasian Drugs Private Limited are
The primary industry of Taraasian Drugs Private Limited is Professional, Scientific And Technical.
Taraasian Drugs Private Limited is unlisted.
The authorized capital of Taraasian Drugs Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Taraasian Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX